Etilevodopa

DB06535ExperimentalSmall molecule

Investigated for use/treatment in parkinson's disease.

Chemical structure of Etilevodopa
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in parkinson's disease.Curator reviewed
Formula / weight
C11H15NO4 · 225.244 g/mol (avg)
Code names
TV-1203

Resolves to

Compound
UNII895X917GYECAS37178-37-3ChEMBLCHEMBL1823681ChEBI135971
Clinical / RWD
RxNorm1421444ATCN04BA06
Structure
InChIKeyNULMGOSOSZBEQL-QMMMGPOBSA-NSMILESCCOC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1
Targets
P35462DRD3

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
50Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 14 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Etilevodopa, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In